KalVista Pharmaceuticals, Inc. (KALV)

NASDAQ: KALV · Real-Time Price · USD

12.59

0.00 (0.00%)

Aug 14, 2025, 2:16 PM - Market open

KalVista Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Aug '25 Aug 14, 2025	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021	2016 - 2020
Market Capitalization	627	685	479	291	312	607	Upgrade
Market Cap Growth	42.97%	42.97%	64.29%	-6.71%	-48.53%	211.76%	Upgrade
Enterprise Value	527	437	411	128	126	558	Upgrade
Last Close Price	12.59	13.77	11.35	8.53	12.73	24.97	Upgrade
PB Ratio	6.57	7.18	2.32	1.81	1.69	2.36	Upgrade
P/TBV Ratio	6.66	7.18	2.32	1.81	1.69	2.36	Upgrade
Debt / Equity Ratio	1.18	1.18	0.04	0.05	0.04	0.02	Upgrade
Quick Ratio	5.22	5.22	9.70	11.18	15.81	26.67	Upgrade
Current Ratio	5.35	5.35	9.90	11.46	16.73	27.04	Upgrade
Return on Equity (ROE)	-121.50%	-121.50%	-68.90%	-53.69%	-37.23%	-27.13%	Upgrade
Return on Assets (ROA)	-48.34%	-48.34%	-41.94%	-35.80%	-25.38%	-19.86%	Upgrade
Return on Capital (ROIC)	-55.75%	-55.75%	-45.82%	-38.23%	-26.46%	-20.78%	Upgrade
Earnings Yield	-28.87%	-26.80%	-26.45%	-31.88%	-26.35%	-7.62%	Upgrade
FCF Yield	-24.13%	-22.40%	-18.64%	-26.23%	-25.31%	-4.98%	Upgrade
Buyback Yield / Dilution	-34.98%	-34.98%	-31.89%	-13.96%	-28.17%	-7.58%	Upgrade

Updated Jul 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q